Cite
Oral mesalamine prevented relapse in patients with Crohn disease who were in remission for < 3 months
MLA
Arvey I. Rogers. “Oral Mesalamine Prevented Relapse in Patients with Crohn Disease Who Were in Remission for < 3 Months.” ACP Journal Club, vol. 119, July 1993, p. 11. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........11b68f7d0c25338a36d2694e070c3d12&authtype=sso&custid=ns315887.
APA
Arvey I. Rogers. (1993). Oral mesalamine prevented relapse in patients with Crohn disease who were in remission for < 3 months. ACP Journal Club, 119, 11.
Chicago
Arvey I. Rogers. 1993. “Oral Mesalamine Prevented Relapse in Patients with Crohn Disease Who Were in Remission for < 3 Months.” ACP Journal Club 119 (July): 11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........11b68f7d0c25338a36d2694e070c3d12&authtype=sso&custid=ns315887.